Destination: The Novo Nordisk Access to Insight initiative seeks to promote research in hemophilia and other bleeding disorders. This Grant will support innovative haemostatic research on patient outcomes, quality of life, and social impacts.
Budget: € 70,000.
Duration: Up to 1 year.
Fill out the form below to receive more information: